Skip to main content

Table 2 Prevalence of hemoglobinopathies and ABO blood groups

From: Effect of iron fortification on anaemia and risk of malaria among Ghanaian pre-school children with haemoglobinopathies and different ABO blood groups

G6PD genotypes

A-A-

 

AA

 

AB

BB

Total

n (%)

96 (11.2)

 

236 (27.6)

 

95 (11.1)

430 (50.1)

857 (100)

Male: female (%)

8.5:2.7

 

14.3:13.3

 

0:11.1

28.1:22.0

51:49

P-values

0.005

 

0.919

 

NA

0.668

0.972

Hb genotypes

Hb AA

Hb AC

Hb CC

Hb AS

Hb SC

Hb SS

Total

n (%)

627 (72.9)

63 (7.3)

15 (1.7)

106 (12.3)

45 (5.2)

4 (0.5)

860(100)

ABO Blood groups

A

B

 

AB

O

 

Total

n (%)

244 (29.6)

192 (23.3)

 

47 (5.7)

341 (41.4)

 

824 (100)

  1. Data reported as the number (n) and percentage (%) of participants, glucose-6-phosphate dehydrogenase (G6PD). For G6PD genotype: male hemizygous (deficient variant or mutant) = A-; male (non-deficient variant) = A; male (wild type) = B; female homozygous (deficient variant or mutant) = A-/A-; female heterozygous (intermediate type) = A/B; and female homozygous (non-deficient variant) = A/A; female homozygous (wild type) = B/B. Haemoglobin (Hb); For Hb genotype: sickling traits (HbAS & HbSC), sickle disorder (HbSS), haemoglobin C traits (HbAC), normal or wild-type haemoglobin (HbAA), variant haemoglobin (HbCC) and 1-sided Fisher's exact tests for p-values